Pacemaker infection due to Mycobacterium fortuitum

Scandinavian Journal of Infectious Diseases

Volumn 37, Issue 1, 2005, Pages 66-68

  Sharma, Sunita ^a   Tleyjeh, Imad M ^a,b   Espinosa, Raul E ^a   Costello, Brian A ^a   Baddour, Larry M ^a  

^a Mayo Clinic   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CLARITHROMYCIN; DOXYCYCLINE; IMIPENEM;

ADULT; ANKLE EDEMA; ANKLE FRACTURE; ARTICLE; ARTIFICIAL HEART PACEMAKER; BACTERIAL ENDOCARDITIS; BACTERIUM IDENTIFICATION; BLOOD CULTURE; BURNING SENSATION; CASE REPORT; CHILL; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; DEVICE INFECTION; DEVICE REMOVAL; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ERYTHEMA; FEMALE; FEVER; FOLLOW UP; GRAM POSITIVE BACTERIUM; HOSPITALIZATION; HUMAN; MYCOBACTERIUM FORTUITUM; NAUSEA; OPEN REDUCTION; OSTEOSYNTHESIS; PATIENT REFERRAL; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

EID: 13644258099     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540410020910     Document Type: Article

References (13)

1. Baddour LM, Bettmann MA, Bolger AF, Epstein AE, Ferrieri P, Gerber MA, et al. AHA Nonvalvular cardiovascular device-related infections. Circulation 2003;108:2015-31.
2. Clegg HW, Foster MT, Sanders WE Jr, Baine WB. Infection due to organisms of Mycobacterium fortuitum complex after augmentation mammaplasty: clinical and epidemiologic features. J Infect Dis 1983;147:427-33.
3. Amin M, Gross J, Andrew C, Furman S. Pacemaker infection with Mycobacterium avium complex. PACE 1991; 14:154.
4. Verghese S, Mullaseri A, Padmaja P, Subhadra AC, Cherian KM. Pacemaker implant site infection caused by atypical mycobacteria. Indian Heart J 1998;50:201-2.
5. Cutay AM, Horowitz HW, Pooley RW, Van Horn K, Wormser GP. Infection of epicardial pacemaker wires due to Mycobacterium abscessus. Clin Infect Dis 1998;26: 520-1.
6. American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacterium. Am J Respir Crit Care Med 1997;1997:S1-25.
7. Victor F, De Place C, Camus C, LeBreton H, Leclercq C, Pavin D, et al. Pacemaker lead infection: echocardiographic features, management, and outcome. Heart 1999;81:82-7.
8. Wallace RJ Jr. The clinical presentation, diagnosis, and therapy of cutaneous and pulmonary infections due to rapidly growing mycobacteria. Clin Chest Med 1989; 10:419-29.
9. Wallace RJ Jr. Infections due to non-tuberculous mycobacteria. In: Mandell GL Bennett BJ, Dolin R, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Disease. Philadelphia: Churchill Livingstone; 2000. p. 2630-6.
10. Klug D, Lacroix D, Savoye C, Goullard L, Grandmougin D, Hennequin JT, et al. Systemic infection related to endocarditis on pacemaker leads. Clinical presentation and management. Circulation 1997;95:2098-107.
11. Wilkoff BL, Byrd CL, Love CJ, Hayes DL, Sellars TD, Schaerf R, et al. Pacemaker lead extraction with the laser sheath: results of the pacing lead extraction with the Excimer sheath (PLEXES) trial. J Am Coll Cardiol 1999; 33:1671-6.
12. Lewis AB, Hayes DL, Holmes DR Jr, Vlietstra RE, Pluth JR, Osborn MJ. Update on infections involving permanent pacemakers. Characterization and management. J Thorac Cardiovasc Surg 1985;89:758-63.
13. Meier-Ewert HK, Gray ME, John RM. Endocardial pacemaker or defibrillator leads with infected vegetations: a single-center experience and consequences of transvenous extraction. Am Heart J 2003;146:339-44.